Related references
Note: Only part of the references are listed.Association between ABCB1 Immunohistochemical Expression and Overall Survival in Gastric Cancer Patients
Juliana de Oliveira et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein
Nobuyuki Yamagishi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Discovery of Novel P-Glycoprotein-Mediated Multidrug Resistance Inhibitors Bearing Triazole Core via Click Chemistry
Baomin Liu et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2014)
Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype
Ana Ferro et al.
EUROPEAN JOURNAL OF CANCER (2014)
Hypoxia-regulated gene network in drug resistance and cancer progression
Shao-Chieh Lin et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2014)
Expression of multidrug resistance proteins in invasive ductal carcinoma of the breast
Weiquan Li et al.
ONCOLOGY LETTERS (2014)
Hypoxia Induced Multidrug Resistance of Laryngeal Cancer Cells via Hypoxia-inducible Factor-1α
Da-Wei Li et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Nuclear NHERF1 expression as a prognostic marker in breast cancer
A. Paradiso et al.
CELL DEATH & DISEASE (2013)
Clinical significance of EBP50 overexpression assessed by quantum dot analysis in gastric cancer
Xiao-Guang Lv et al.
ONCOLOGY LETTERS (2013)
Expression and significance of hypoxia-inducible factor-1α and MDR1/P-glycoprotein in laryngeal carcinoma tissue and hypoxic Hep-2 cells
Jin Xie et al.
ONCOLOGY LETTERS (2013)
Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells
Shuling Huang et al.
CANCER LETTERS (2012)
Overexpression of nuclear NHERF1 in advanced colorectal cancer: Association with hypoxic microenvironment and tumor invasive phenotype
Andrea Malfettone et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2012)
Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance
Thomas Karn et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp
Qingchun He et al.
ONCOLOGY REPORTS (2011)
NHERF1/EBP50 in Breast Cancer: Clinical Perspectives
Antonia Bellizzi et al.
BREAST CARE (2010)
Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells
Zhenyu Ding et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Expression of P-glycoprotein and Multidrug Resistance-associated Protein is Associated with Multidrug Resistance in Gastric Cancer
H-W Xu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer
Langmei Deng et al.
MEDICAL ONCOLOGY (2010)
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer.
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
NHERF1/EBP50 Is a New Marker in Colorectal Cancer
Yuho Hayashi et al.
NEOPLASIA (2010)
Phase I dose-escalating study of 24-h continuous infusion of 5-fluorouracil in combination with weekly docetaxel and cisplatin in patients with advanced gastric cancer
Biyun Wang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Biological role of NHERF1 protein expression in breast cancer
Anita Mangia et al.
HISTOPATHOLOGY (2009)
The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer
Wen-Qing Hu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Down-regulation of Na+/H+ exchanger regulatory factor 1 increases expression and function of multidrug resistance protein 4
Md. Tozanunel Hoque et al.
CANCER RESEARCH (2008)
Roles of NHERF1/EBP50 in cancer
Maria-Magdalena Georgescu et al.
CURRENT MOLECULAR MEDICINE (2008)
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer
Lili Liu et al.
CANCER SCIENCE (2008)
Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer
J. Song et al.
HISTOPATHOLOGY (2007)
The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells
Rosa A. Cardone et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Hypoxia-inducible factor-1α expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas
E. A. Griffiths et al.
BRITISH JOURNAL OF CANCER (2007)
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial
D. Santini et al.
BMC CANCER (2006)
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer
P Correale et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines
RA Cardone et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
NHERF (Na+/H+ Exchanger Regulatory Factor) gene mutations in human breast cancer
JL Dai et al.
ONCOGENE (2004)
EBP50, a β-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma
T Shibata et al.
HEPATOLOGY (2003)
C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins
T Hegedüs et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Expression of multidrug resistance-associated protein 1, P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection
JH Choi et al.
BRITISH JOURNAL OF CANCER (2002)
Involvement of hypoxia-inducible factor 1 in human cancer
GL Semenza
INTERNAL MEDICINE (2002)
Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation
JW Voltz et al.
ONCOGENE (2001)
NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas
AO Stemmer-Rachamimov et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
